PEMIGATINIB
Active substance: pemigatinib
TABLET · PEMIGATINIB 13.5 mg/1
United StatesActive
Marketing holder: Lonza Tampa LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- PEMIGATINIB · 13.5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-f8d8-7ec9-98fd-5e9c42318be5,01a12091-bb33-7839-a692-cbc66829b810,01a12091-bb3b-71a3-9084-d78030bcc876,01a12096-09d8-79f7-97d5-393244ff2d80,01a1209a-bdfc-7d01-9887-7f86fe9f4de1;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 70277-503
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 70277-503 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70277-503 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70277-503 · Verified 2026-10-09 · open in source